Schneyer Mark C. — SEC insider filings
SEC reporting owner CIK 1899977. 31 insider filings on record with FilingPulse; latest filed 2026-10-30.
Transaction summary — filings shown
Covers all 31 filings on record, filed 2022-02-25 to 2026-10-30. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 32 legs across 28 filings — 153,455 shares, $3,447,550 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 69.
- Largest priced transaction: sale of 22,000 shares @ $25.18 ($554,024) in ACADIA PHARMACEUTICALS INC, filed 2025-08-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ACADIA PHARMACEUTICALS INC (ACAD) | EVP, CHIEF FINANCIAL OFFICER | 31 | — | 32 legs · 153,455 sh · $3,447,550 | 69 |
Insider filings — Schneyer Mark C.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-30 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Grant/award (A): 6,815 @ $0 · Sale (S): 3,321 @ $20.88 | EDGAR |
| 2026-08-07 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 5,849 @ $17.84 · Sale (S): 5,849 @ $29.00 · Option exercise (M): 14,292 @ $17.84 · Sale (S): 5,000 @ $29 · Sale (S): 9,292 @ $29.34 · Option exercise (M): 5,849 (derivative) @ $0 · +1 more | EDGAR |
| 2026-05-05 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 6,815 · Sale (S): 3,506 @ $21.79 · Option exercise (M): 6,815 (derivative) @ $0 | EDGAR |
| 2026-04-07 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 5,276 · Sale (S): 2,709 @ $22.20 · Option exercise (M): 5,276 (derivative) @ $0 | EDGAR |
| 2026-03-26 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 8,138 · Sale (S): 4,177 @ $21.47 · Option exercise (M): 6,178 · Sale (S): 3,171 @ $21.65 · Sale (S): 37 @ $21.72 · Option exercise (M): 8,138 (derivative) @ $0 · +1 more | EDGAR |
| 2026-03-10 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Grant/award (A): 90,691 (derivative) @ $0 · Grant/award (A): 26,382 (derivative) @ $0 | EDGAR |
| 2025-11-19 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 9,913 · Option exercise (M): 9,913 · Sale (S): 10,262 @ $23.69 · Option exercise (M): 9,913 (derivative) @ $0 · Option exercise (M): 9,913 (derivative) @ $0 | EDGAR |
| 2025-09-16 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Grant/award (A): 6,815 @ $0 · Sale (S): 3,498 @ $23.65 | EDGAR |
| 2025-08-19 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Sale (S): 22,000 @ $25.18 | EDGAR |
| 2025-05-19 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Sale (S): 2,000 @ $25 | EDGAR |
| 2025-05-02 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 6,815 · Sale (S): 3,498 @ $14.60 · Option exercise (M): 6,815 (derivative) @ $0 | EDGAR |
| 2025-04-08 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 5,275 · Sale (S): 2,708 @ $14.82 · Option exercise (M): 5,275 (derivative) @ $0 | EDGAR |
| 2025-03-26 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 6,178 · Sale (S): 3,171 @ $17.05 · Grant/award (A): 110,761 (derivative) @ $0 · Grant/award (A): 32,552 (derivative) @ $0 · Option exercise (M): 6,178 (derivative) @ $0 | EDGAR |
| 2025-02-25 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 1,353 · Sale (S): 773 @ $19.96 · Option exercise (M): 1,353 (derivative) @ $0 | EDGAR |
| 2024-11-19 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 9,913 · Option exercise (M): 9,913 · Sale (S): 10,259 @ $16.81 · Option exercise (M): 9,913 (derivative) @ $0 · Option exercise (M): 9,913 (derivative) @ $0 | EDGAR |
| 2024-08-20 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Grant/award (A): 5,275 @ $0 · Grant/award (A): 13,629 @ $0 · Sale (S): 9,733 @ $15.28 | EDGAR |
| 2024-06-11 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 1,893 · Sale (S): 975 @ $14.79 · Option exercise (M): 1,893 (derivative) @ $0 | EDGAR |
| 2024-05-03 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 6,814 · Sale (S): 3,503 @ $16.94 · Option exercise (M): 6,814 (derivative) @ $0 | EDGAR |
| 2024-04-09 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 5,275 · Sale (S): 2,716 @ $17.87 · Option exercise (M): 5,275 (derivative) @ $0 | EDGAR |
| 2024-03-27 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Grant/award (A): 10,550 @ $0 · Sale (S): 5,434 @ $17.90 · Grant/award (A): 80,564 (derivative) @ $0 · Grant/award (A): 24,714 (derivative) @ $0 | EDGAR |
| 2024-02-27 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 1,353 · Sale (S): 772 @ $24.67 · Option exercise (M): 1,353 (derivative) @ $0 | EDGAR |
| 2023-11-21 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 4,956 · Option exercise (M): 4,956 · Sale (S): 5,108 @ $22.64 · Option exercise (M): 4,956 (derivative) @ $0 · Option exercise (M): 4,956 (derivative) @ $0 | EDGAR |
| 2023-08-23 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Sale (S): 10,000 @ $29.00 | EDGAR |
| 2023-06-12 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 1,893 @ $0 · Sale (S): 974 @ $25.02 · Option exercise (M): 1,893 (derivative) @ $0 | EDGAR |
| 2023-05-19 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 14,869 · Option exercise (M): 14,869 · Sale (S): 15,310 @ $22.50 · Option exercise (M): 14,869 (derivative) @ $0 · Option exercise (M): 14,869 (derivative) @ $0 | EDGAR |
| 2023-05-03 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Grant/award (A): 89,936 (derivative) @ $0 · Grant/award (A): 27,259 (derivative) @ $0 | EDGAR |
| 2023-04-07 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 5,275 · Sale (S): 1,916 @ $18.16 · Option exercise (M): 5,275 (derivative) @ $0 | EDGAR |
| 2023-02-27 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 1,353 · Sale (S): 577 @ $18.78 · Option exercise (M): 1,353 (derivative) @ $0 | EDGAR |
| 2022-06-10 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 1,893 @ $0 · Sale (S): 653 @ $17.91 · Option exercise (M): 1,893 (derivative) @ $0 | EDGAR |
| 2022-04-07 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Grant/award (A): 72,414 (derivative) @ $0 · Grant/award (A): 21,101 (derivative) @ $0 | EDGAR |
| 2022-02-25 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 1,352 @ $0 · Sale (S): 553 @ $23.80 · Option exercise (M): 1,352 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-07-14 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1899977 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs